SEK 3.06
(0.0%)
Year | Net Income | Net Income Growth |
---|---|---|
2023 | -11.01 Million SEK | -39.92% |
2022 | -7.86 Million SEK | -1.25% |
2021 | -7.77 Million SEK | -364.89% |
2020 | 2.93 Million SEK | -35.98% |
2019 | 4.58 Million SEK | 14221.88% |
2018 | 32 Thousand SEK | 0.0% |
Year | Net Income | Net Income Growth |
---|---|---|
2024 Q3 | 2.91 Million SEK | 566.67% |
2024 Q2 | -624 Thousand SEK | -98.1% |
2024 Q1 | -315 Thousand SEK | 96.75% |
2023 Q3 | 47 Thousand SEK | 105.47% |
2023 FY | -11.01 Million SEK | -39.92% |
2023 Q4 | -9.7 Million SEK | -20748.94% |
2023 Q2 | -859 Thousand SEK | -26.51% |
2023 Q1 | -679 Thousand SEK | 50.44% |
2022 Q3 | 927 Thousand SEK | 127.01% |
2022 Q2 | -3.43 Million SEK | 18.52% |
2022 Q1 | -4.21 Million SEK | 45.27% |
2022 FY | -7.86 Million SEK | -1.25% |
2022 Q4 | -1.37 Million SEK | -247.79% |
2021 FY | -7.77 Million SEK | -364.89% |
2021 Q4 | -7.69 Million SEK | -1853.08% |
2021 Q3 | 439 Thousand SEK | 898.18% |
2021 Q2 | -55 Thousand SEK | 95.71% |
2021 Q1 | -1.28 Million SEK | 54.42% |
2020 FY | 2.93 Million SEK | -35.98% |
2020 Q4 | -2.81 Million SEK | 0.0% |
2020 Q3 | -2.81 Million SEK | -232.2% |
2020 Q2 | 2.12 Million SEK | 0.0% |
2020 Q1 | 2.12 Million SEK | 0.0% |
2019 FY | 4.58 Million SEK | 14221.88% |
2018 FY | 32 Thousand SEK | 0.0% |
Name | Net Income | Net Income Difference |
---|---|---|
Aino Health AB (publ) | -10.66 Million SEK | -3.274% |
Bonzun AB (publ) | 13.88 Million SEK | 179.298% |
Kontigo Care AB (publ) | 212 Thousand SEK | 5293.396% |
RaySearch Laboratories AB (publ) | 81.57 Million SEK | 113.497% |
Surgical Science Sweden AB (publ) | 233.97 Million SEK | 104.706% |